Bone Marrow TransplantationTransplantation, HomologousHematopoietic Stem Cell TransplantationStem Cell TransplantationGraft vs Host DiseaseTransplantation ConditioningBone MarrowHematologic NeoplasmsTransplantation, AutologousBone Marrow CellsCytomegalovirus InfectionsHistocompatibility TestingRoseolovirus InfectionsAspergillosisStem CellsTissue DonorsTransplantation ChimeraTreatment OutcomeWhole-Body IrradiationGraft SurvivalLeukemiaBusulfanHematopoietic Stem CellsRetrospective StudiesCytomegalovirusAnemia, AplasticKidney TransplantationImmunosuppressive AgentsRecurrenceHistocompatibilityBone and BonesPeripheral Blood Stem Cell TransplantationRemission InductionLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGraft RejectionLeukemia, Myeloid, AcuteGraft vs Leukemia EffectCombined Modality TherapyTime FactorsTransplantationCyclophosphamidePrecursor Cell Lymphoblastic Leukemia-LymphomaLymphocyte DepletionHepatic Veno-Occlusive DiseaseBone Marrow PurgingImmunocompromised HostLiver TransplantationGraft vs Tumor EffectSurvival AnalysisImmunosuppressionTransplantation, IsogeneicAcute DiseaseTransplantation ImmunologyMyelodysplastic SyndromesT-LymphocytesLymphocyte TransfusionOpportunistic InfectionsMice, Inbred C57BLSurvival RateMultiple MyelomaLeukocyte TransfusionHeart TransplantationHematologic DiseasesCyclosporineMyeloablative AgonistsHematopoiesisLeukemia, MyeloidHLA AntigensVidarabineFollow-Up StudiesSalvage TherapyAntineoplastic Combined Chemotherapy ProtocolsDisease-Free SurvivalHematopoietic Stem Cell MobilizationLymphoma, Non-HodgkinCell DifferentiationBone Marrow DiseasesRadiation ChimeraAntilymphocyte SerumLung TransplantationTransplantsChimerismFatal OutcomeCord Blood Stem Cell TransplantationMycosesMelphalanAntigens, CD34SiblingsMinor Histocompatibility AntigensFlow CytometryPrognosisVirus ActivationGranulocyte Colony-Stimulating FactorGanciclovirLymphoproliferative DisordersEmbryonic Stem CellsGraft vs Host ReactionNeoplasm, ResidualNuclear FamilyActuarial Analysis